CVI Holdings’s Orion Biotech Opportunities Corp. Class A Ordinary Share ORIA Stock Holding History

CVI Holdings’s Portfolio ORIA Stock Details ORIA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-99,375	Closed	-$1.02M	–	415
2023 Q1	$1.02M	Sell	99,375 -1,877	-2%	-$19.1K	0.38%	84
2022 Q4	$1.02M	Sell	101,252 -417	-0.4%	-$4.15K	0.13%	188
2022 Q3	$1M	Hold	101,669	–	–	0.08%	333
2022 Q2	$990K	Hold	101,669	–	–	0.07%	361
2022 Q1	$992K	Buy	101,669 +1,669	+2%	+$16.2K	0.07%	390
2021 Q4	$967K	Hold	100,000	–	–	0.06%	380
2021 Q3	$966K	Buy	+100,000	New	+$976K	0.06%	381

CVI Holdings's ORIA Position: Q2 2023 in Review

CVI Holdings sold out of Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) in Q2 2023, closing a stake of 99,375 shares — an estimated $1.02M sold.

CVI Holdings first reported a position in ORIA in Q3 2021 and held it in 7 quarters. The position peaked at $1.02M in Q4 2022. 0 funds tracked by Wall St. Rank hold ORIA as of Q2 2023.

CVI Holdings reported no remaining Orion Biotech Opportunities Corp. Class A Ordinary Share position as of Q2 2023 after selling out during the quarter.
CVI Holdings sold 99,375 Orion Biotech Opportunities Corp. Class A Ordinary Share shares in Q2 2023, an estimated $1.02M.
CVI Holdings first reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share in Q3 2021 and held it in 7 quarters.
CVI Holdings's Orion Biotech Opportunities Corp. Class A Ordinary Share position peaked at $1.02M in Q4 2022.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Class A Ordinary Share as of Q2 2023.

Based on CVI Holdings's 13F filing for Q2 2023, filed 11 Aug 2023.